This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4ami
From Proteopedia
(Difference between revisions)
| Line 2: | Line 2: | ||
<StructureSection load='4ami' size='340' side='right' caption='[[4ami]], [[Resolution|resolution]] 3.20Å' scene=''> | <StructureSection load='4ami' size='340' side='right' caption='[[4ami]], [[Resolution|resolution]] 3.20Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4ami]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[4ami]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Common_turkey Common turkey]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4AMI OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4AMI FirstGlance]. <br> |
| - | </td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=2CV:HEGA-10'>2CV</scene>, <scene name='pdbligand=G90:2-[(2S)-3-[[1-(1H-INDOL-3-YL)-2-METHYL-PROPAN-2-YL]AMINO]-2-OXIDANYL-PROPOXY]BENZENECARBONITRILE'>G90</scene>< | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=2CV:HEGA-10'>2CV</scene>, <scene name='pdbligand=G90:2-[(2S)-3-[[1-(1H-INDOL-3-YL)-2-METHYL-PROPAN-2-YL]AMINO]-2-OXIDANYL-PROPOXY]BENZENECARBONITRILE'>G90</scene></td></tr> |
| - | <tr><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1dep|1dep]], [[2vt4|2vt4]], [[2y00|2y00]], [[2y01|2y01]], [[2y02|2y02]], [[2y03|2y03]], [[2y04|2y04]], [[2ycw|2ycw]], [[2ycx|2ycx]], [[2ycy|2ycy]], [[2ycz|2ycz]], [[4amj|4amj]]</td></tr> | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1dep|1dep]], [[2vt4|2vt4]], [[2y00|2y00]], [[2y01|2y01]], [[2y02|2y02]], [[2y03|2y03]], [[2y04|2y04]], [[2ycw|2ycw]], [[2ycx|2ycx]], [[2ycy|2ycy]], [[2ycz|2ycz]], [[4amj|4amj]]</td></tr> |
| - | <tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ami FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ami OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4ami RCSB], [http://www.ebi.ac.uk/pdbsum/4ami PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ami FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ami OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4ami RCSB], [http://www.ebi.ac.uk/pdbsum/4ami PDBsum]</span></td></tr> |
| - | <table> | + | </table> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 22: | Line 22: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Common turkey]] |
| - | [[Category: Edwards, P C | + | [[Category: Edwards, P C]] |
| - | [[Category: Leslie, A G | + | [[Category: Leslie, A G]] |
| - | [[Category: Tate, C G | + | [[Category: Tate, C G]] |
| - | [[Category: Warne, T | + | [[Category: Warne, T]] |
[[Category: 7tmr beta1-adrenoceptor]] | [[Category: 7tmr beta1-adrenoceptor]] | ||
[[Category: Biased agonist]] | [[Category: Biased agonist]] | ||
[[Category: Membrane protein]] | [[Category: Membrane protein]] | ||
[[Category: Stabilising mutation]] | [[Category: Stabilising mutation]] | ||
Revision as of 07:47, 3 December 2014
Turkey beta1 adrenergic receptor with stabilising mutations and bound biased agonist bucindolol
| |||||||||||
